GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model ...

Led by Dr. Nishant Kumar, the initiative offers tests, prescription glasses, and awareness to combat diabetes-induced ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

Researchers have conducted one of the largest eye studies ever, revealing that retinal thickness could play a key role in ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...